Pivikto 150 mg Tablet
$407,98
$398,91
Pivikto 150 mg Tablet serves as an innovative treatment option for individuals battling advanced hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, specifically in postmenopausal women and men. As a phosphatidylinositol 3-kinase (PI3K) inhibitor, Pivikto works by targeting specific pathways involved in cancer cell growth, providing a mechanism for combating tumors that are resistant to traditional hormonal therapies. This medication is particularly beneficial for patients who possess mutations in the PIK3CA gene and have not responded to other hormonal treatments, as it can be effectively combined with fulvestrant to enhance therapeutic outcomes. It’s crucial for patients to consult their healthcare provider regarding potential side effects and interactions, as Pivikto may not be suitable for everyone. Regular monitoring is recommended to ensure safety and efficacy during treatment. By understanding how Pivikto functions and its role in advanced breast cancer management, patients can make informed decisions about their treatment options. Always discuss your medical history and current medications with your healthcare professional before starting this therapy.
數量
Active Pharmaceutical Ingredient
Uses
• Pivikto 150 mg tablet is primarily used for the treatment of breast cancer in postmenopausal women and men. This medication targets cancerous cells, helping to slow their growth and spread. Patients may notice symptoms such as lumps in the breast tissue or changes in breast appearance. The use of Pivikto 150 mg tablet can be a critical part of a comprehensive treatment plan for individuals facing this diagnosis.
• In addition to its role in treating breast cancer, Pivikto 150 mg tablet can be beneficial in managing hormone receptor-positive tumors. These types of tumors rely on hormones to grow, and Pivikto 150 mg tablet helps to disrupt this process. By effectively targeting these tumors, the medication assists in reducing the risk of cancer recurrence. This makes Pivikto 150 mg tablet an important option for ongoing cancer care.
• Pivikto 150 mg tablet may also be utilized in combination with other therapies to enhance treatment efficacy. This approach allows healthcare providers to tailor cancer treatment plans to the specific needs of the patient. By integrating Pivikto 150 mg tablet with other modalities, such as chemotherapy or radiation, a more robust defense against cancer can be achieved. The flexibility of Pivikto 150 mg tablet makes it a valuable asset in multidisciplinary cancer care.
• The administration of Pivikto 150 mg tablet is often considered when patients exhibit specific clinical features associated with breast cancer. These can include the presence of a palpable mass or alterations in breast symmetry. By addressing these symptoms effectively, Pivikto 150 mg tablet contributes to a more comprehensive management of breast cancer. Its role is crucial in helping patients navigate their treatment journey and improve their overall quality of life.
Benefits
Breast cancer: Pivikto 150 mg Tablet helps treat breast cancer and may be used alone or in combination with other medicines or treatments, such as chemotherapy. It relieves the symptoms of breast cancer, such as lumps in the breast, bloody discharge from the nipple, or changes in the shape or texture of the breast. Pivikto 150 mg kills or stops the growth of cancer cells and also prevents them from multiplying. Discuss with your doctor if any of the side effects bother you.
Side Effects
As with all medicines, Pivikto 150 mg Tablet has the potential to cause certain side effects. If you experience any of these side effects, it is important to seek immediate medical advice from your doctor. Your doctor will be able to make recommendations on how to effectively manage or minimise the impact of these side effects.
Most Common Side Effects
• Heartburn
• Headache
• Itching
• Dry Skin
• Dry Mouth
• Vaginal Dryness
• Fever
• Swelling of the Arms Or Legs
Common Side Effects
• Nausea
• Vomiting
• Loss of appetite
• Weight loss
• Feeling weak
• Tired
• Mouth sores
• Rash
• Hair loss
• Abnormal blood tests
How To Use
It is recommended that you take Pivikto 150 mg Tablet immediately after a meal. However, for optimal results, it is important to take Pivikto 150 mg Tablet at the same time every day. Your doctor will determine the appropriate dosage and frequency based on your specific condition, which may change over time. It is of the utmost importance that you follow your doctor's instructions and do not change the dosage or frequency without their guidance. Taking Pivikto Tablet in incorrect or excessive amounts can lead to serious side effects. Although it may take several weeks or months for the full effects of treatment to be observed, it is essential to consult your doctor before discontinuing use.
Safety Advice
• Alcohol: The use of alcohol is not recommended while taking Alpelisib Tablet 150 mg due to the increased risk of side effects or possible interference with the effectiveness of Pivikto 150 mg. It is best to consult your doctor or pharmacist before consuming alcohol while taking any medication.
• Kidney: Patients with mild to moderate kidney disease can safely use Pivikto Tablet without dose adjustment. However, caution should be exercised when using this product in patients with severe kidney disease.
• Breastfeeding: The use of Pivikto Tablet while breastfeeding is not recommended as it may pass into breast milk and cause harm to the baby. If you are breastfeeding and taking Alpelisib Tablet 150 mg, it is important to discuss the potential risks and benefits of continuing to breastfeed with your doctor. Your doctor's expertise will help you make an informed decision about the health of both you and your baby.
• Liver: Pivikto 150 mg Tablet is safe to use in patients with liver disease. No dose adjustment of Pivikto 150 mg is recommended. If you experience any side effects please consult your doctor.Patients with liver disease can safely use Pivikto 150 mg Tablet without the need to adjust the dose of Pivikto 150 mg. If you experience any side effects, it is recommended that you consult your doctor for further advice.
• Pregnancy: The use of Pivikto 150 mg is not recommended during pregnancy as there is evidence from animal studies of potential harm to the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to discuss the potential risks and benefits of taking Pivikto Tablet during pregnancy with your doctor. Your doctor will be able to help you make an informed decision based on the best interests of both you and your baby.
• Driving: The effect of Pivikto 150 mg on driving performance is not yet known. If you experience symptoms that affect your ability to concentrate and react, it is best not to drive.